Effect of cardiac resynchronization therapy on cardiotrophin-1 circulating levels in patients with heart failure

Internal and Emergency Medicine

Volumn 9, Issue 1, 2014, Pages 43-50

  Limongelli, Giuseppe ^a   Roselli, Teo ^a   Pacileo, Giuseppe ^a   Calabró, Paolo ^a   Maddaloni, Valeria ^a   Masarone, Daniele ^a   Riegler, Lucia ^a   Gravino, Rita ^a   Scarafile, Raffaella ^a   Salerno, Gemma ^a   Miele, Tiziana ^a   D'Andrea, Antonello ^a   Santangelo, Lucio ^a   Romano, Massimo ^a   Di Salvo, Giovanni ^a   Russo, Maria Giovanna ^a   Calabró, Raffaele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cardiac resynchronization therapy; Cardiotrophin 1; Heart failure

Indexed keywords

CARDIOTROPHIN 1; CYTOKINE;

ADULT; AGED; BLOOD; CARDIAC RESYNCHRONIZATION THERAPY; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; EXERCISE TEST; FEMALE; HEART FAILURE; HEART VENTRICLE REMODELING; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; CARDIAC RESYNCHRONIZATION THERAPY; CYTOKINES; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; VENTRICULAR REMODELING;

EID: 84895064349     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0740-2     Document Type: Article

References (23)

1. Tang WH, Francis GS (2010) The year in heart failure. J Am Coll Cardiol 55: 688-696.
2. Erikson H (1995) Heart failure: a growing public health problem. J Intern Med 237: 135-141.
3. Nagueh SF (2008) Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. J Am Coll Cardiol 51: 18-22.
4. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L (2005) Cardiac Resynchronization-Heart Failure (CARE-CHF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352: 1539-1549.
5. Barth AS, Aiba T, Halperin V, DiSilvestre D, Chakir K, Colantuoni C, Tunin RS, Dimaano VL, Yu W, Abraham TP, Kass DA, Tomaselli GF (2009) Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circ Cardiovasc Genet 2: 371-378.
6. Vanderheyden M, Mullens W, Delrue L, Goethals M, de Bruyne B, Wijns W, Geelen P, Verstreken S, Wellens F, Bartunek J (2008) Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol 51: 129-136.
7. Francia P, Salvati A, Balla C, De Paolis P, Pagannone E, Borro M, Gentile G, Simmaco M, De Biase L, Volpe M (2007) Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin. Eur J Heart Fail 9: 306-309.
8. D'Ascia C, Cittadini A, Monti MG, Riccio G, Saccà L (2006) Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression and apoptotic death in failing human myocardium. Eur Heart J 27: 201-206.
9. Lappegård KT, Bjørnstad H (2006) Anti-inflammatory effect of cardiac resynchronization therapy. Pacing ClinElectrophysiol 29: 753-758.
10. Spragg DD, Kass DA (2006) Pathobiology of left ventricular dyssynchrony and resynchronization. ProgCardiovasc Dis 49: 26-41.
11. Calabrò P, Limongelli G, Riegler L, Maddaloni V, Palmieri R, Golia E, Roselli T, Masarone D, Pacileo G, Golino P, Calabrò R (2009) Novel insights into the role of cardiotrophin-1 in cardiovascular diseases. J Mol Cell Cardiol 46: 142-148.
12. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh SM et al (1995) Expression cloning of cardiotrophin1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 92: 1142-1146.
13. Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vernallis AB, Heath JK, Pennica D, Wood WI, Chien KR (1996) Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 271: 9535-9545.
14. Jougasaki M, Tachibana I, Luchner A, Leskinen H, Redfield MM, Burnett JC Jr (2000) Augmented cardiac cardiotrophin-1 in experimental congestive heart failure. Circulation 101: 14-17.
15. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Wang X, Asai S, Tsuji T, Tanaka H, Saito Y, Kuwahara K, Nakao K, Kinoshita M (2001) Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy. J Am Coll Cardiol 38: 1485-1490.
16. D'Andrea A, Caso P, Cuomo S, Scarafile R, Salerno G, Limongelli G, Di Salvo G, Severino S, Ascione L, Calabrò P, Romano M, Romano G, Santangelo L, Maiello C, Cotrufo M, Calabrò R (2007) Effect of dynamic myocardial dyssynchrony on mitral regurgitation during supine bicycle exercise stress echocardiography in patients with idiopathic dilated cardiomyopathy and 'narrow' QRS. Eur Heart J 28: 2738-2748.
17. D'Andrea A, Caso P, Scarafile R, Riegler L, Salerno G, Castaldo F, Gravino R, Cocchia R, Del Viscovo L, Limongelli G, Di Salvo G, Ascione L, Iengo R, Cuomo S, Santangelo L, Calabrò R (2009) Effects of global longitudinal strain and total scar burden on response to cardiac resynchronization therapy in patients with ischaemic dilated cardiomyopathy. Eur J Heart Fail 11: 58-67.
18. Auger D, van Bommel RJ, Bertini M, Delgado V, Ng AC, Ewe SH, Shanks M, Marsan NA, Mooyaart EA, Witkowski T, Poldermans D, Schalij MJ, Bax JJ (2010) Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy. Am Heart J 160: 737-743.
19. Asai S, Saito Y, Kuwahara K, Mizuno Y, Yoshimura M, Higashikubo C et al (2000) The heart is a source of circulating cardiotrophin-1 in humans. Biochem Biophys Res Commun 279: 320-323.
20. Zolk O, Engmann S, Munzel F, Krajcik R (2005) Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue. Am J Physiol Endocrinol Metab 288: E1214-E1221.
21. Zolk O, Ng LL, O'Brien RJ, Weyand M, Eschenhagen T (2002) Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance. Circulation 106: 1442-1446.
22. Tsutamoto T, Asai S, Tanaka T, Sakai H, Nishiyama K, Fujii M et al (2007) Plasma level of cardiotrophin-1 as a prognostic predictor in patients with chronic heart failure. Eur J Heart Fail 9: 1032-1037.
23. NeriSerneri GG, Boddi M, Modesti PA, Cecioni I, Coppo M, Padeletti L, Michelucci A, Colella A, Galanti G (2001) Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res 89: 977-982.